Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 63,900 shares, a growth of 428.1% from the December 15th total of 12,100 shares. Based on an average daily trading volume, of 124,300 shares, the days-to-cover ratio is presently 0.5 days.
Fresenius SE & Co. KGaA Price Performance
Shares of OTCMKTS:FSNUY traded down $0.12 on Monday, reaching $8.89. 85,939 shares of the company were exchanged, compared to its average volume of 127,662. The company has a current ratio of 1.36, a quick ratio of 1.05 and a debt-to-equity ratio of 0.57. Fresenius SE & Co. KGaA has a 1-year low of $6.57 and a 1-year high of $9.78. The company has a 50-day moving average of $8.87 and a 200-day moving average of $8.88. The firm has a market cap of $19.86 billion, a price-to-earnings ratio of 12.36 and a beta of 1.02.
Analyst Upgrades and Downgrades
Separately, Citigroup upgraded shares of Fresenius SE & Co. KGaA to a "strong-buy" rating in a research note on Friday, October 25th.
Check Out Our Latest Report on FSNUY
About Fresenius SE & Co. KGaA
(
Get Free Report)
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Fresenius SE & Co. KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius SE & Co. KGaA wasn't on the list.
While Fresenius SE & Co. KGaA currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.